Now Cellucor is being sued!
GNC, Cellucor Sports Nutrition and others have been accused of misleading consumers over the source, regulatory status and safety of the controversial stimulant DMAA (1,3 Dimethylamylamine) in a new class action lawsuit filed in California.
GNC: 'There is also no scientific/medical evidence that demonstrates any causal link between DMAA and any adverse medical condition, let alone a death'
In a civil action filed in the US District Court, Central District of California against GNC, Cellucor Sports Nutrition, Woodbolt Distribution, Woodbolt Management and Woodbolt International, plaintiff Lynette Bates argues that the defendants misled shoppers by selling Cellucor's C-4 Extreme pre-workout supplement containing the “synthetic and dangerous stimulant DMAA”.
The plaintiff seeks damages on behalf of all persons in the US who purchased C-4 Extreme at any time during the past four years. The new action, filed on February 15, alleges that during the class period, the defendants engaged in an illegal and deceptive practice of promoting, marketing, distributing and/or selling C-4 Extreme as a natural dietary supplement when, in fact, the DMAA in C-4 Extreme is “wholly synthetic, manufactured and not derived from the geranium plan
The action acknowledges that Cellucor may have recently reformulated its products to remove DMAA from some iterations of C-4 Extreme [DMAA is no longer listed in the C-4 ingredients list on the Cellucor website] but notes that it has been replaced with another stimulant called Synephrine HCL.
